FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Youngro Byun

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Anatomy

Physiology

Activities & Behaviors

Materials Testing

Co-author Network

Publications

TOP 3
Jee-Heon Jeong; Dong Yun Lee; Haeshin Lee; Simmyung Yook; Cheol-Hee Ahn; Youngro Byun
Effects of surface camouflaged islet transplantation on pathophysiological progression in a db/db type 2 diabetic mouse model.
Ok-Cheol Jeon; Seulki Lee; Hyun Tae Moon; Jae Hyung Park; Jin Woo Park; Taslim A Al-Hilal; Seung Rim Hwang; Youngro Byun
Oral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primates.
Bok-Hyeon Im; Jee-Heon Jeong; Ju Eun Kim; Dong Yun Lee; Cheol-Hee Ahn; Muhammad R Haque; Youngro Byun
The effects of 8-arm-PEG-catechol/heparin shielding system and immunosuppressive drug, FK506 on the survival of intraportally allotransplanted islets.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Youngro Byun (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jee-Heon Jeong; Dong Yun Lee; Haeshin Lee; Simmyung Yook; Cheol-Hee Ahn; Youngro Byun
Effects of surface camouflaged islet transplantation on pathophysiological progression in a db/db type 2 diabetic mouse model.
Biochemical and biophysical research communications 2013;433(4):513-8.
2013: Ok-Cheol Jeon; Seulki Lee; Hyun Tae Moon; Jae Hyung Park; Jin Woo Park; Taslim A Al-Hilal; Seung Rim Hwang; Youngro Byun
Oral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primates.
Pharmaceutical research 2013;30(4):959-67.
2013: Bok-Hyeon Im; Jee-Heon Jeong; Ju Eun Kim; Dong Yun Lee; Cheol-Hee Ahn; Muhammad R Haque; Youngro Byun
The effects of 8-arm-PEG-catechol/heparin shielding system and immunosuppressive drug, FK506 on the survival of intraportally allotransplanted islets.
Biomaterials 2013;34(8):2098-106.
2013: Sang Mun Bae; Youngro Byun; Seung Woo Chung; In-San Kim; Jong-Ho Kim; Sang Yoon Kim; Byung-Heon Lee; Rang-Woon Park
An apoptosis-homing peptide-conjugated low molecular weight heparin-taurocholate conjugate with antitumor properties.
Biomaterials 2013;34(8):2077-86.
2013: Jin Woo Park; Seung Rim Hwang; Ok-Cheol Jeon; Hyun Tae Moon; Youngro Byun
Enhanced oral absorption of ibandronate via complex formation with bile acid derivative.
Journal of pharmaceutical sciences 2013;102(2):341-6.
2012: Seung Woo Chung; Ok Cheol Jeon; Han Sung Kim; Sang Yoon Kim; Beom Suk Lee; Hui Sun Lee; Myungjin Lee; Jooho Park; Rang-Woon Park; Sang Mun Bae; Han Choe; Youngro Byun
Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge.
Biomaterials 2012;33(35):9070-9.
2012: Asarasin Adulnirath; Seung Woo Chung; Seung Rim Hwang; Ji-Young Kim; Sang Yoon Kim; Hyun Tae Moon; Jooho Park; Victor C Yang; Youngro Byun
Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor.
Journal of controlled release : official journal of the Controlled Release Society 2012;164(1):8-16.
2012: Tae Hyung Kim; Seulki Lee; Sung Mook Lim; Yu Seok Youn; Youngro Byun; Xiaoyuan Chen; Ki Young Choi; Hai Hua Jiang; Kang Choon Lee
Site-specific PEGylated Exendin-4 modified with a high molecular weight trimeric PEG reduces steric hindrance and increases type 2 antidiabetic therapeutic effects.
Bioconjugate chemistry 2012;23(11):2214-20.
2012: Seung Rim Hwang; Ok-Cheol Jeon; Jin Hee Kang; Young Mo Kang; Han Sung Kim; Sung-Hyun Kim; Dong-Hyun Seo; Victor C Yang; Taslim A Al-Hilal; Young-Tae Chang; Youngro Byun
Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis.
Journal of controlled release : official journal of the Controlled Release Society 2012;163(3):374-84.
2012: Jian Zhang; Hongyan Zhu; Youngro Byun; Dawei Deng; Victor C Yang; Yueqing Gu
Folate-conjugated thermo-responsive micelles for tumor targeting.
Journal of biomedical materials research. Part A 2012;100(11):3134-42.
2012: Tae Hyung Kim; Seulki Lee; Sung Mook Lim; Yu Seok Youn; Youngro Byun; Xiaoyuan Chen; Hai Hua Jiang; Young Gi Jo; Kang Choon Lee
PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting.
Journal of controlled release : official journal of the Controlled Release Society 2012;162(2):422-8.
2012: So Jin Lee; Seung Young Lee; Solki Min; Kinam Park; Kyung Eun Lee; Seulki Lee; Youngro Byun; Kuiwon Choi; Yongseok Choi; Jun-Uk Chu; Myung Sook Huh; Hyesung Jeon; Seo Young Jeong; Kwangmeyung Kim; Heebeom Koo; Ick Chan Kwon
Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment.
Angewandte Chemie (International ed. in English) 2012;51(29):7203-7.
2012: Yoon Shin Park; Youngro Byun; Allan E David; Huining He; Yongzhuo Huang; Jun-Beom Park; Victor C Yang
In vivo delivery of cell-permeable antisense hypoxia-inducible factor 1α oligonucleotide to adipose tissue reduces adiposity in obese mice.
Journal of controlled release : official journal of the Controlled Release Society 2012;161(1):1-9.
2012: Seung Woo Chung; Taslim A Hil-lal; Youngro Byun
Strategies for non-invasive delivery of biologics.
Journal of drug targeting 2012;20(6):481-501.
2012: Ji-young Kim; Kwangmeyung Kim; Sunil Kim; Sang Yoon Kim; Yu-Kyoung Oh; Jooho Park; Gayong Shim; Victor C Yang; Ick Chan Kwon; Hyun-woo Choi; Seung Woo Chung; Chan-Wha Kim; Youngro Byun
Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex.
Biomaterials 2012;33(17):4424-30.
2012: Jun-Beom Park; Yoon Shin Park; Youngro Byun; Chong-Pyoung Chung; Chia-Ying Lin; Huina Zhang; Victor C Yang
Simvastatin maintains osteoblastic viability while promoting differentiation by partially regulating the expressions of estrogen receptors α.
The Journal of surgical research 2012;174(2):278-83.
2012: Jee-Heon Jeong; Yoonsuk Jung; Dong Yun Lee; Minhyung Lee; Simmyung Yook; Cheol-Hee Ahn; Bok-Hyeon Im; Youngro Byun
Functional enhancement of beta cells in transplanted pancreatic islets by secretion signal peptide-linked exendin-4 gene transduction.
Journal of controlled release : official journal of the Controlled Release Society 2012;159(3):368-75.
2012: Kwangwon Seo; Youngro Byun; Seung Woo Chung; Dukjoon Kim
Paclitaxel loaded nano-aggregates based on pH sensitive polyaspartamide amphiphilic graft copolymers.
International journal of pharmaceutics 2012;424(1-2):26-32.
2012: Simmyung Yook; Cheol-Hee Ahn; Sung Woo Hong; Bok Hyeon Im; Jee-Heon Jeong; Yoon Suk Jung; Dong Yun Lee; Haeshin Lee; Minhyung Lee; Jun Beom Park; Jin Won Seo; Youngro Byun
Molecularly engineered islet cell clusters for diabetes mellitus treatment.
Cell transplantation 2012;21(8):1775-89.
2012: Yoon Suk Jung; Dong Yun Lee; Jun-Beom Park; Jinwon Seo; Victor C Yang; Simmyung Yook; Sung Woo Hong; Bok-Hyeon Im; Jee-Heon Jeong; Youngro Byun
Surface modification of pancreatic islets using heparin-DOPA conjugate and anti-CD154 mAb for the prolonged survival of intrahepatic transplanted islets in a xenograft model.
Biomaterials 2012;33(1):295-303.
2011: Jee-Heon Jeong; Yoonsuk Jung; Cao Duy Khue; Dong Yun Lee; Haeshin Lee; Jun-Beom Park; Jinwon Seo; Simmyung Yook; Cheol-Hee Ahn; Seonki Hong; Sung Woo Hong; Bok-Hyeon Im; Youngro Byun
Surface camouflage of pancreatic islets using 6-arm-PEG-catechol in combined therapy with tacrolimus and anti-CD154 monoclonal antibody for xenotransplantation.
Biomaterials 2011;32(31):7961-70.
2011: Inseong You; Youngro Byun; Sung Min Kang; Haeshin Lee
Enhancement of blood compatibility of poly(urethane) substrates by mussel-inspired adhesive heparin coating.
Bioconjugate chemistry 2011;22(7):1264-9.
2011: Sang Kyoon Kim; Sang Yoon Kim; Dong Yun Lee; Youngro Byun; June Huh; Hyun Tae Moon
Physicochemical conjugation with deoxycholic acid and dimethylsulfoxide for heparin oral delivery.
Bioconjugate chemistry 2011;22(7):1451-8.
2011: Soondong Lee; Gayong Shim; Youngro Byun; Chan-Wha Kim; Sunil Kim; Young Bong Kim; Yu-Kyoung Oh
Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes.
Nucleic acid therapeutics 2011;21(3):165-72.
2011: J W Park; T A Al-Hilal; O C Jeon; C Y Kim; Sang Kyoon Kim; Kyung-Min Lim; H T Moon; Youngro Byun
Pharmacokinetic evaluation of an oral tablet form of low-molecular-weight heparin and deoxycholic acid conjugate as a novel oral anticoagulant.
Thrombosis and haemostasis 2011;105(6):1060-71.
2011: So Jin Lee; Youngro Byun; Kuiwon Choi; Yongseok Choi; Myung Sook Huh; Hayoung Jeong; Seo Young Jeong; Kwangmeyung Kim; Heebeom Koo; Ick Chan Kwon
Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy.
Journal of controlled release : official journal of the Controlled Release Society 2011;152(1):21-9.
2011: Tae Hyung Kim; Hai Hua Jiang; Seulki Lee; Yu Seok Youn; Chan Woong Park; Youngro Byun; Xiaoyuan Chen; Kang Choon Lee
Mono-PEGylated dimeric exendin-4 as high receptor binding and long-acting conjugates for type 2 anti-diabetes therapeutics.
Bioconjugate chemistry 2011;22(4):625-32.
2010: Jin Woo Park; Ok Cheol Jeon; Sang Kyoon Kim; Taslim Ahmed Al-Hilal; Shun Ji Jin; Hyun Tae Moon; Victor C Yang; Sang Yoon Kim; Youngro Byun
High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives.
Journal of controlled release : official journal of the Controlled Release Society 2010;148(3):317-26.
2010: Youngro Byun; Yu-Kyoung Oh; Peter D Senter; Soo-Chang Song
Meeting report: International Symposium on Intelligent Drug Delivery Systems, 2010.
Molecular pharmaceutics 2010;7(6):2310-1.
2010: Jin Sup Eom; Kyung Suck Koh; Taslim A Al-Hilal; Jin Woo Park; Ok Cheol Jeon; Hyun Tae Moon; Youngro Byun
Antithrombotic efficacy of an oral low molecular weight heparin conjugated with deoxycholic asset on microsurgical anastomosis in rats.
Thrombosis research 2010;126(3):e220-4.
2010: Sang Kyoon Kim; Seulki Lee; Sunji Jin; Hyun Tae Moon; Ok Cheol Jeon; Dong Yun Lee; Youngro Byun
Diabetes correction in pancreatectomized canines by orally absorbable insulin-deoxycholate complex.
Molecular pharmaceutics 2010;7(3):708-17.
2010: Jin Woo Park; Ok Cheol Jeon; Sang Kyoon Kim; Taslim Ahmed Al-Hilal; Hyun Tae Moon; Choong Yong Kim; Youngro Byun
Anticoagulant efficacy of solid oral formulations containing a new heparin derivative.
Molecular pharmaceutics 2010;7(3):836-43.
2010: Su Young Chae; Cheng-Hao Jin; Jae Hee Shin; Sohee Son; Tae Hyung Kim; Seulki Lee; Yu Seok Youn; Youngro Byun; Myung-Shik Lee; Kang Choon Lee
Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs.
Journal of controlled release : official journal of the Controlled Release Society 2010;142(2):206-13.
2010: Ohm Divyam Krishna; Ok Cheol Jeon; Kwangmeyung Kim; Youngro Byun; Hyun Tae Moon
Drug release from a chemically-anchored PEG/phospholipid monolayer onto polymer-coated metallic stents.
Journal of biomaterials science. Polymer edition 2010;21(6):789-802.
2009: Dong Yun Lee; Sung Won Lee; Sang Kyoon Kim; Myungjin Lee; Hyo Won Chang; Hyun Tae Moon; Youngro Byun; Sang Yoon Kim
Antiangiogenic activity of orally absorbable heparin derivative in different types of cancer cells.
Pharmaceutical research 2009;26(12):2667-76.
2009: Ji-Young Kim; Jin-Ki Kim; Jeong-Sook Park; Youngro Byun; Chong-Kook Kim
The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator.
Biomaterials 2009;30(29):5751-6.
2009: Esak Lee; Yoo-Shin Kim; Sang Mun Bae; Sang Kyoon Kim; Shunji Jin; Seung Woo Chung; Myungjin Lee; Hyun Tae Moon; Ok-Cheol Jeon; Rang-Woon Park; In-San Kim; Youngro Byun; Sang Yoon Kim
Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor.
International journal of cancer. Journal international du cancer 2009;124(12):2755-65.
2009: Zheng Yun Cui; Min Jae Park; Jeeyun Lee; Jin Seok Ahn; Myung-Ju Ahn; Soo Won Seo; Jin Woo Park; Youngro Byun; Keunchil Park
Modest anti-cancer activity of a bile acid acylated heparin derivative in a PC14PE6 induced orthotopic lung cancer model.
Cancer research and treatment : official journal of Korean Cancer Association 2009;41(2):80-6.
2008: Kyeongsoon Park; Yoo-Shin Kim; Gee Young Lee; Rang-Woon Park; In-San Kim; Sang Yoon Kim; Youngro Byun
Tumor endothelial cell targeted cyclic RGD-modified heparin derivative: inhibition of angiogenesis and tumor growth.
Pharmaceutical research 2008;25(12):2786-98.
2008: Kwang Jae Cho; Hyun Tae Moon; Go-Eun Park; Ok Chul Jeon; Youngro Byun; Yong-Kyu Lee
Preparation of sodium deoxycholate (DOC) conjugated heparin derivatives for inhibition of angiogenesis and cancer cell growth.
Bioconjugate chemistry 2008;19(7):1346-51.
2008: Dong Yun Lee; Kyeongsoon Park; Sang Kyoon Kim; Rang-Woon Park; Ick Chan Kwon; Sang Yoon Kim; Youngro Byun
Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2841-9.
2008: Kyeongsoon Park; Gee Young Lee; Rang-Woon Park; In-San Kim; Sang Yoon Kim; Youngro Byun
Combination therapy of heparin-deoxycholic acid conjugate and doxorubicin against squamous cell carcinoma and B16F10 melanoma.
Pharmaceutical research 2008;25(2):268-76.
2008: Dong Yun Lee; Sang Jin Park; Jong Hee Nam; Youngro Byun
Optimal aggregation of dissociated islet cells for functional islet-like cluster.
Journal of biomaterials science. Polymer edition 2008;19(4):441-52.
2007: Sang Kyoon Kim; Dong Yun Lee; Choong Yong Kim; Jong Hee Nam; Hyun Tae Moon; Youngro Byun
A newly developed oral heparin derivative for deep vein thrombosis: non-human primate study.
Journal of controlled release : official journal of the Controlled Release Society 2007;123(2):155-63.
2007: Gee Young Lee; Kyeongsoon Park; Sang Yoon Kim; Youngro Byun
MMPs-specific PEGylated peptide-DOX conjugate micelles that can contain free doxorubicin.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;67(3):646-54.
2007: Gee Young Lee; Sang Kyoon Kim; Youngro Byun
Glucosylated heparin derivatives as non-toxic anti-cancer drugs.
Journal of controlled release : official journal of the Controlled Release Society 2007;123(1):46-55.
2007: Dong Yun Lee; Jisook Lee; Seulki Lee; Sang Kyoon Kim; Youngro Byun
Liphophilic complexation of heparin based on bile acid for oral delivery.
Journal of controlled release : official journal of the Controlled Release Society 2007;123(1):39-45.
2007: Choong-Yong Kim; JeeEun Kim; KangHyun Han; SangKyoon Kim; KuiLea Park; Youngro Byun
Toxicity screening after repeated dose of a newly developed oral heparin derivative in male cynomolgus monkeys.
The Journal of toxicological sciences 2007;32(4):411-20.
2007: Dong Yun Lee; Sang Jin Park; Seulki Lee; Jong Hee Nam; Youngro Byun
Highly poly(ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication.
Tissue engineering 2007;13(8):2133-41.
2007: Sang Kyoon Kim; Dong Yun Lee; Eunhye Lee; Yong-kyu Lee; Choong Yong Kim; Hyun Tae Moon; Youngro Byun
Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant.
Journal of controlled release : official journal of the Controlled Release Society 2007;120(1-2):4-10.
2007: Yi-Rac Choi; Su Young Chae; Cheol-Hee Ahn; Minhyung Lee; Seungjoon Oh; Youngro Byun; Byoung Doo Rhee; Kyung Soo Ko
Development of polymeric gene delivery carriers: PEGylated copolymers of L-lysine and L-phenylalanine.
Journal of drug targeting 2007;15(6):391-8.
2007: Kyeongsoon Park; Seok Ki Lee; Dai Hyun Son; Soo Ah Park; Kwangmeyung Kim; Hyo Won Chang; Eun-Jeong Jeong; Rang-Woon Park; In-San Kim; Ick Chan Kwon; Youngro Byun; Sang Yoon Kim
The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative.
Biomaterials 2007;28(16):2667-76.
2007: Dong Yun Lee; Sang Kyoon Kim; Yoo Shin Kim; Dai Hyun Son; Jong Hee Nam; In-San Kim; Rang-Woon Park; Sang Yoon Kim; Youngro Byun
Suppression of angiogenesis and tumor growth by orally active deoxycholic acid-heparin conjugate.
Journal of controlled release : official journal of the Controlled Release Society 2007;118(3):310-7.
2007: Mi Kyung Yu; Dong Yun Lee; Yoo Shin Kim; Kyeongsoon Park; Soo Ah Park; Dai Hyun Son; Gee Young Lee; Jong Hee Nam; Sang Yoon Kim; In-San Kim; Rang-Woon Park; Youngro Byun
Antiangiogenic and apoptotic properties of a novel amphiphilic folate-heparin-lithocholate derivative having cellular internality for cancer therapy.
Pharmaceutical research 2007;24(4):705-14.
2007: Dong Yun Lee; Jong Hee Nam; Youngro Byun
Functional and histological evaluation of transplanted pancreatic islets immunoprotected by PEGylation and cyclosporine for 1 year.
Biomaterials 2007;28(11):1957-66.
2007: Yong-Kyu Lee; Jae Hyung Park; Hyun Tae Moon; Dong Yun Lee; Jung Han Yun; Youngro Byun
The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer.
Biomaterials 2007;28(8):1523-30.
2007: Yong Woo Cho; Soo Ah Park; Tae Hee Han; Dai Hyun Son; Ji Sun Park; Seung Jun Oh; Dae Hyuk Moon; Kyung-Ja Cho; Cheol-Hee Ahn; Youngro Byun; In-San Kim; Ick Chan Kwon; Sang Yoon Kim
In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications.
Biomaterials 2007;28(6):1236-47.
2007: Kyeongsoon Park; Yoo-Shin Kim; Gee Young Lee; Ju-Ock Nam; Seok Ki Lee; Rang-Woon Park; Sang Yoon Kim; In-San Kim; Youngro Byun
Antiangiogenic effect of bile acid acylated heparin derivative.
Pharmaceutical research 2007;24(1):176-85.
2006: Gee Young Lee; Kyeongsoon Park; Jong Hee Nam; Sang Yoon Kim; Youngro Byun
Anti-tumor and anti-metastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice.
Journal of drug targeting 2006;14(10):707-16.
2006: Kyeongsoon Park; Gee Young Lee; Yoo-Shin Kim; Mikyung Yu; Rang-Woon Park; In-San Kim; Sang Yoon Kim; Youngro Byun
Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity.
Journal of controlled release : official journal of the Controlled Release Society 2006;114(3):300-6.
2006: Yongdoo Choi; Sang Yoon Kim; Kyeongsoon Park; Jehoon Yang; Kyung-Ja Cho; Hyun Ja Kwon; Youngro Byun
Chemopreventive efficacy of all-trans-retinoic acid in biodegradable microspheres against epithelial cancers: results in a 4-nitroquinoline 1-oxide-induced oral carcinogenesis model.
International journal of pharmaceutics 2006;320(1-2):45-52.
2006: Sang Kyoon Kim; Dong Yoon Lee; Choong Yong Kim; Hyun Tae Moon; Youngro Byun
Prevention effect of orally active heparin derivative on deep vein thrombosis.
Thrombosis and haemostasis 2006;96(2):149-53.
2006: Dong Yun Lee; Seulki Lee; Jong Hee Nam; Youngro Byun
Minimization of immunosuppressive therapy after islet transplantation: combined action of heme oxygenase-1 and PEGylation to islet.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(8):1820-8.
2006: Seulki Lee; Y S Youn; S-H Lee; Youngro Byun; K C Lee
PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice.
Diabetologia 2006;49(7):1608-11.
2006: Seulki Lee; Sang Kyoon Kim; Dong Yun Lee; Su Young Chae; Youngro Byun
Pharmacokinetics of a new, orally available ceftriaxone formulation in physical complexation with a cationic analogue of bile acid in rats.
Antimicrobial agents and chemotherapy 2006;50(5):1869-71.
2006: Yong-kyu Lee; Sang Kyoon Kim; Dong Yun Lee; Seulki Lee; Choong-Yong Kim; Ho-Chul Shin; Hyun Tae Moon; Youngro Byun
Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.
Journal of controlled release : official journal of the Controlled Release Society 2006;111(3):290-8.
2006: Dong Yun Lee; Sang Jin Park; Jong Hee Nam; Youngro Byun
A new strategy toward improving immunoprotection in cell therapy for diabetes mellitus: long-functioning PEGylated islets in vivo.
Tissue engineering 2006;12(3):615-23.
2006: Dong Yun Lee; Sang Jin Park; Jong Hee Nam; Youngro Byun
A combination therapy of PEGylation and immunosuppressive agent for successful islet transplantation.
Journal of controlled release : official journal of the Controlled Release Society 2006;110(2):290-5.
2006: Sang Kyoon Kim; Bagalkot Vaishali; Eunhye Lee; Seulki Lee; Yong-Kyu Lee; Tadiparthi Suresh Kumar; Hyun Tae Moon; Youngro Byun
Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation.
Thrombosis research 2006;117(4):419-27.
2005: Ohm Divyam Krishna; Kwangmeyung Kim; Youngro Byun
Covalently grafted phospholipid monolayer on silicone catheter surface for reduction in platelet adhesion.
Biomaterials 2005;26(34):7115-23.
2005: Seulki Lee; Sang Kyoon Kim; Dong Yun Lee; Kyeongsoon Park; Tadiparthi Suresh Kumar; Su Young Chae; Youngro Byun
Cationic analog of deoxycholate as an oral delivery carrier for ceftriaxone.
Journal of pharmaceutical sciences 2005;94(11):2541-8.
2005: Sang Kyoon Kim; Kwangmeyung Kim; Seulki Lee; Kyeongsoon Park; Jae Hyung Park; Ick Chan Kwon; Kuiwon Choi; Choong-Yong Kim; Youngro Byun
Evaluation of absorption of heparin-DOCA conjugates on the intestinal wall using a surface plasmon resonance.
Journal of pharmaceutical and biomedical analysis 2005;39(5):861-70.
2005: Sang Kyoon Kim; Eun Hye Lee; Bagalkot Vaishali; Seulki Lee; Yong-kyu Lee; Choong-Yong Kim; Hyun Tae Moon; Youngro Byun
Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates.
Journal of controlled release : official journal of the Controlled Release Society 2005;105(1-2):32-42.
2005: Hyun Kyun Kim; Kwangmeyung Kim; Youngro Byun
Preparation of a chemically anchored phospholipid monolayer on an acrylated polymer substrate.
Biomaterials 2005;26(17):3435-44.
2005: Kyeongsoon Park; Je Hoon Yang; Yongdoo Choi; Chulkyu Lee; Sang Yoon Kim; Youngro Byun
Chemoprevention of 4-NQO-induced oral carcinogenesis by co-administration of all-trans retinoic acid loaded microspheres and celecoxib.
Journal of controlled release : official journal of the Controlled Release Society 2005;104(1):167-79.
2005: Seulki Lee; Kwangmeyung Kim; Tadiparthi Suresh Kumar; Jisook Lee; Sang Kyoon Kim; Dong Yun Lee; Yong-kyu Lee; Youngro Byun
Synthesis and biological properties of insulin-deoxycholic acid chemical conjugates.
Bioconjugate chemistry 2005;16(3):615-20.
2005: Kwangmeyung Kim; Youngro Byun; Chulhee Kim; Tae Chul Kim; Do Young Noh; Kwanwoo Shin
Combined study of X-ray reflectivity and atomic force microscopy on a surface-grafted phospholipid monolayer on a solid.
Journal of colloid and interface science 2005;284(1):107-13.
2005: Sang-Heon Lee; Seulki Lee; Yu Seok Youn; Dong Hee Na; Su Young Chae; Youngro Byun; Kang Choon Lee
Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1.
Bioconjugate chemistry 2005;16(2):377-82.
2005: Seulki Lee; J Lee; D Y Lee; S K Kim; Y Lee; Youngro Byun
A new drug carrier, Nalpha-deoxycholyl-L: -lysyl-methylester, for enhancing insulin absorption in the intestine.
Diabetologia 2005;48(3):405-11.
2005: Yong Yeon Kim; Su Young Chae; Sungwon Kim; Youngro Byun; You Han Bae
Improved phenotype of rat islets in a macrocapsule by co-encapsulation with cross-linked Hb.
Journal of biomaterials science. Polymer edition 2005;16(12):1521-35.
2004: Kyeongsoon Park; Kwangmeyung Kim; Ick Chan Kwon; Sang Kyoon Kim; Seulki Lee; Dong Yun Lee; Youngro Byun
Preparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugates.
Langmuir : the ACS journal of surfaces and colloids 2004;20(26):11726-31.
2004: Kyoung Ho Lee; Joon Koo Han; Youngro Byun; Hyun Tae Moon; Chang Jin Yoon; Seung-Jin Kim; Byung Ihn Choi
Heparin-coated angiographic catheters: an in vivo comparison of three coating methods with different heparin release profiles.
Cardiovascular and interventional radiology 2004;27(5):507-11.
2004: Jun Yeon Won; Eui-Cheol Nam; Seung Joo Yoo; Hyun Ja Kwon; Soo-Jong Um; Hye Sook Han; Sun Hee Kim; Youngro Byun; Sang Yoon Kim
The effect of cellular retinoic acid binding protein-I expression on the CYP26-mediated catabolism of all-trans retinoic acid and cell proliferation in head and neck squamous cell carcinoma.
Metabolism: clinical and experimental 2004;53(8):1007-12.
2004: Ji Yeon Jang; Dong Yun Lee; Sang Jin Park; Youngro Byun
Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets.
Biomaterials 2004;25(17):3663-9.
2004: Kwangmeyung Kim; Sungpil Cho; Jae Hyung Park; Youngro Byun; Hesson Chung; Ick Chan Kwon; Seo Young Jeong
Surface plasmon resonance studies of the direct interaction between a drug/intestinal brush border membrane.
Pharmaceutical research 2004;21(7):1233-9.
2004: Kwangmeyung Kim; Kwanwoo Shin; Hyunkyoon Kim; Chulhee Kim; Youngro Byun
In situ photopolymerization of a polymerizable poly(ethylene glycol)-covered phospholipid monolayer on a methacryloyl-terminated substrate.
Langmuir : the ACS journal of surfaces and colloids 2004;20(13):5396-402.
2004: Dong Yun Lee; Jong Hee Nam; Youngro Byun
Effect of polyethylene glycol grafted onto islet capsules on prevention of splenocyte and cytokine attacks.
Journal of biomaterials science. Polymer edition 2004;15(6):753-66.
2004: Sungpil Cho; Jae Hyung Park; Jaehoon Yu; Yong-Kyu Lee; Youngro Byun; Hesson Chung; Ick Chan Kwon; Seo Young Jeong
Preparation and characterization of reconstructed small intestinal brush border membranes for surface plasmon resonance analysis.
Pharmaceutical research 2004;21(1):55-60.
2004: Kwangmeyung Kim; Chulhee Kim; Youngro Byun
Biostability and biocompatibility of a surface-grafted phospholipid monolayer on a solid substrate.
Biomaterials 2004;25(1):33-41.
2003: Yongdoo Choi; Sang Yoon Kim; Sun Hee Kim; Jehoon Yang; Kyeongsoon Park; Youngro Byun
Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft.
International journal of cancer. Journal international du cancer 2003;107(1):145-8.
2003: Kyoung Ho Lee; Joon Koo Han; Kwang Gi Kim; Youngro Byun; Chang Jin Yoon; Seung-Jin Kim; Byung Ihn Choi
Clogging of drainage catheters: quantitative and longitudinal assessment by monitoring intracatheter pressure in catheters and rabbits.
Radiology 2003;227(3):833-8.
2003: Kwangmeyung Kim; Chulhee Kim; Youngro Byun
Preparation of a stable phospholipid monolayer grafted onto a methacryloyl-terminated substrate as blood compatible materials.
Journal of biomaterials science. Polymer edition 2003;14(9):887-902.
2003: Ji Hoon Jeong; Youngro Byun; Tae Gwan Park
Synthesis and characterization of poly(L-lysine)-g-poly(D,L-lactic-co-glycolic acid) biodegradable micelles.
Journal of biomaterials science. Polymer edition 2003;14(1):1-11.
2002: Dong Yun Lee; Kyungwook Yang; Sangjun Lee; Su Young Chae; Kwang-Won Kim; Moon Kyu Lee; Duck Jong Han; Youngro Byun
Optimization of monomethoxy-polyethylene glycol grafting on the pancreatic islet capsules.
Journal of biomedical materials research 2002;62(3):372-7.
2002: Sang Yoon Kim; Seung Joo Yoo; Hyun Ja Kwon; Sun Hee Kim; Youngro Byun; Kwang-Sun Lee
Retinoic acid 4-hydroxylase-mediated catabolism of all-trans retinoic acid and the cell proliferation in head and neck squamous cell carcinoma.
Metabolism: clinical and experimental 2002;51(4):477-81.
2002: Hyun Tae Moon; Yong-Kyu Lee; Joon Koo Han; Youngro Byun
Improved blood compatibility by sustained release of heparin-deoxycholic acid conjugates in a PCL-PEG multiblock copolymer matrix.
Journal of biomaterials science. Polymer edition 2002;13(7):817-28.
2002: Yongdoo Choi; Sang Yoon Kim; Sun Hee Kim; Tae Gwan Park; Hyun Tae Moon; Youngro Byun
In vivo biocompatibility studies of poly(D,L-lactide)/poly(ethylene glycol)-poly(L-lactide) microspheres containing all-trans-retinoic acid.
Journal of biomaterials science. Polymer edition 2002;13(3):301-22.
2001: Y Lee; Jong Hee Nam; H C Shin; Youngro Byun
Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent.
Circulation 2001;104(25):3116-20.
2001: Sang Yoon Kim; C Kim; In-Seob Han; S C Lee; Sun Hee Kim; Kwang-Sun Lee; Y Choi; Youngro Byun
Inhibition effect of new farnesol derivatives on all-trans-retinoic acid metabolism.
Metabolism: clinical and experimental 2001;50(11):1356-60.
2001: Yongdoo Choi; Sang Yoon Kim; M H Moon; Sun Hee Kim; K S Lee; Youngro Byun
Poly(ethylene glycol)-poly(L-lactide) diblock copolymer prevents aggregation of poly(L-lactide) microspheres during ethylene oxide gas sterilization.
Biomaterials 2001;22(9):995-1004.
2001: Y Choi; Sang Yoon Kim; S H Kim; K S Lee; C Kim; Youngro Byun
Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres.
International journal of pharmaceutics 2001;215(1-2):67-81.
2001: Y C Ah; Yongdoo Choi; Sang Yoon Kim; Sun Hee Kim; K S Lee; Youngro Byun
Effects of ethylene oxide gas sterilization on physical properties of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) microspheres.
Journal of biomaterials science. Polymer edition 2001;12(7):783-99.
2000: Kwangmeyung Kim; C Kim; Youngro Byun
Preparation of a PEG-grafted phospholipid Langmuir-Blodgett monolayer for blood-compatible material.
Journal of biomedical materials research 2000;52(4):836-40.
2000: Y Lee; S H Kim; Youngro Byun
Oral delivery of new heparin derivatives in rats.
Pharmaceutical research 2000;17(10):1259-64.
1998: Y Lee; Hyun Tae Moon; Youngro Byun
Preparation of slightly hydrophobic heparin derivatives which can be used for solvent casting in polymeric formulation.
Thrombosis research 1998;92(4):149-56.
1998: Youngro Byun; Victor C Yang
Delivery system for targeted thrombolysis without the risk of hemorrhage.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1998;44(5):M638-41.
1998: Sang Yoon Kim; In-Seob Han; H K Yu; Hye-Ree Lee; J W Chung; Jee-Ho Choi; Sun Hee Kim; Youngro Byun; Thomas Carey; Kwang-Sun Lee
The induction of P450-mediated oxidation of all-trans retinoic acid by retinoids in head and neck squamous cell carcinoma cell lines.
Metabolism: clinical and experimental 1998;47(8):955-8.
1996: Youngro Byun; T Wang; J S Kim; Victor C Yang
Optimization and assessment of the in vivo efficacy of a heparin removing bio-reactor using mathematical modeling.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1996;42(5):M782-7.
1995: Youngro Byun; J H Yun; I S Han; Y Fu; J N Shanberge; Victor C Yang
A protamine filter for extracorporeal heparin removal. Development, testing, blood compatibility evaluation, and future direction.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 1995;41(3):M301-5.